Dermatology

The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.

Latest News

AJMC Q&A with Elizabeth Garcia Creighton | Background image credit: ipopba - stock.adobe.com
Navigating Challenges in Pediatric Dermatology Access, Addressing Disparities: Elizabeth Garcia Creighton

August 17th 2025

Pediatric dermatology faces access disparities due to lack of awareness, language barriers, and training gaps in recognizing diverse skin conditions.

Hidradenitis suppurativa. | Image Credit: Kristina Blokhin - stock.adobe.com
GLP-1s Show Promise for Patients With Hidradenitis Suppurativa and Obesity

August 15th 2025

AJMC Q&A with Elizabeth Garcia Creighton | Background image credit: ipopba - stock.adobe.com
Challenges in Getting Access to an Initial Pediatric Dermatology Appointment: Elizabeth Garcia Creighton

August 10th 2025

Hidradenitis suppurativa. | Image Credit: JPC-PROD - stock.adobe.com
Comparative Efficacy of Hidradenitis Suppurativa Drugs Examined in Absence of Head-to-Head Trials

August 5th 2025

The FDA has issued a complete response letter for RP1 plus nivolumab for advanced melanoma after a PD-1 inhibitor–containing regimen. | Image credit: ra2studio - stock.adobe.com
RP1 Plus Nivolumab Receives CRL for Advanced Melanoma

July 24th 2025

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives
Continuing Medical Education
View All
August 19th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 19th 2025

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

August 19, 2025 | 1:00 PM & 8:00 PM ET
August 19th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

a man holds a smartphone
August 2nd 2023

Digital App Successfully Detects Skin Cancers

Heather Raglin
Study finds that use of mHealth app could be useful in early detection of skin cancer but cautions that overdiagnosis is a possibility.
pills, syringe, and a paper that says "Kidney disease"
August 1st 2023

Patients With HS Should Be Screened for CKD

Justina Petrullo
A possible association between hidradenitis suppurativa (HS) with chronic kidney disease (CKD) suggests that patients with HS who present signs of CKD should be assessed by a nephrologist, suggests a study.
Screenshot of Haley Naik, MD, smiling
July 30th 2023

Dr Haley Naik: Improved Medical Education Can Help Reduce Diagnostic Delays of HS

Laura Joszt, MA
Some populations face longer diagnostic delays for hidradenitis suppurativa (HS), but medical education can help improve knowledge of common dermatologic diseases and reduce delays in diagnosis, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
mother holding baby
July 24th 2023

Survey Finds Women With HS Possess Higher Infertility Rates

Justina Petrullo
Women with hidradenitis suppurativa (HS) reported higher fertility rates compared to the general population, and most said HS symptoms did not change with fertility treatments.
Screenshot of Haley Naik, MD, smiling
July 23rd 2023

Patients With Hidradenitis Suppurativa Face Many Barriers When Accessing Care, Says Dr Haley Naik

Laura Joszt, MA
Some of the many barriers patients with hidradenitis suppurativa (HS) face include accessing knowledgeable providers, insurance coverage of treatment, and the way the health care system is set up, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
a patient is having their skin examined
July 22nd 2023

PAKT Tool May Be Able to Improve Outcomes for Patients with AK

Justina Petrullo
The personalizing actinic keratosis treatment (PAKT) tool may have the ability to strengthen patient-centric management of actinic keratoses (AK) in clinical practice, account for patient goals, and form reasonable treatment and care outcomes.
image of a person with itchy skin
July 21st 2023

HS Associated With Multiple Comorbidities, Underreported, Says Review

Justina Petrullo
Hidradenitis suppurativa (HS) is associated with multiple comorbidities and is underreported in developing countries, necessitating further research.
pill capsules on a table
July 17th 2023

OTC Treatment Options for Pesky Summer Rashes

Renata Block, MMS, PA-C
The American Skin Association estimated that 50 million Americans are exposed to urushiol yearly, the most common contact allergen in the United States.
Screenshot of Emma Guttman-Yassky, MD, PhD, smiling
July 16th 2023

Dr Emma Guttman-Yassky: Strong Real-World Results of Biologics, JAK Inhibitors in AD

Laura Joszt, MA
Some of the results with biologics and Janus kinase (JAK) inhibitors for atopic dermatitis have been better in practice compared with clinical trials, said Emma Guttman-Yassky, MD, PhD, FAAD, of the Icahn School of Medicine at Mount Sinai.
Book with title Hidradenitis Suppurativa on a table: © Vitalii Vodolazskyi - stock.adobe.com
July 12th 2023

Hidradenitis Suppurativa Not a Risk Factor for Severe COVID-19

Jared Kaltwasser
Patients with the chronic skin condition hidradenitis suppurativa were less likely to be hospitalized with COVID-19 vs a control group.
young woman with closed eyes touching face with acne isolated on beige: © LIGHTFIELD STUDIOS - stock.adobe.com
July 9th 2023

Acne Scarring Leaves a Lasting Psychosocial Impact

Jared Kaltwasser
More attention should be paid to prevent acne scarring and address the psychosocial consequences associated with it, authors argue.
person: © vegefox.com - stock.adobe.com
July 5th 2023

Certain Response Skills May Help Address Stigma Among Patients With Skin Conditions

Jaime Rosenberg
Although previous research has explored and documented the prevalence of stigma facing people with chronic skin conditions, less is known about how patients respond to such stigma.
Financial concept meaning Hidradenitis Suppurativa with phrase on the page: © Yurii Kibalnik - stock.adobe.com
July 2nd 2023

Secukinumab Potentially Effective, Safe in Patients With HS Not Responding to Adalimumab

Jaime Rosenberg
This retrospective study showed that anti–interleukin-17 drug secukinumab yielded favorable results in a small group of patients with severe hidradenitis suppurativa (HS).
a health provider types on a computer
June 26th 2023

Telemedicine Effective for Diagnosis, Treatment of Pediatric Dermatologic Conditions

Justina Petrullo
Telemedicine is effective to diagnose and treat various dermatologic conditions in the pediatric population.
trans flag paint on hand | Image credit: Nito - stock.adobe.com.
June 24th 2023

Increasing Awareness of Gender-Diverse Patient Concerns in Dermatology

Emma Andrus
Matthew Mansh, MD, FAAD, discusses inequities faced by transgender and gender-diverse patient populations.
Doctor consoling patient
June 22nd 2023

Research Highlights Unmet Needs for Patients With Hidradenitis Suppurativa

Gianna Melillo
The findings are based on survey responses and focus group transcripts reflecting the experiences of nine patients.
Book with title Venous thromboembolism VTE: © Vitalii Vodolazskyi - stock.adobe.com
June 16th 2023

Bullous Pemphigoid Linked With 2-Fold Increased Risk of VTE

Gianna Melillo
Past research shows no meaningfully increased risk of venous thromboembolism (VTE) in patients with more common chronic inflammatory skin diseases.
Dermatologist examining moles of patient in clinic: © Pixel-Shot - stock.adobe.com
June 13th 2023

Low Risk of Melanoma-Specific Mortality Seen in Patients With MIS

Gianna Melillo
The incidence rate of melanoma in situ (MIS) has sharply risen since 1975.
Secukinumab: © luchschenF - stock.adobe.com
June 10th 2023

Real-World Data Suggest Long-Term Treatment With Secukinumab Is Safe, Effective

Gianna Melillo
Findings are based on a retrospective, multicenter study carried out in Spain.
Book with title Hidradenitis Suppurativa on a table: © Vitalii Vodolazskyi - stock.adobe.com
June 9th 2023

Research Shows Lower SES Linked With HS in French Adults

Gianna Melillo
Lower socioeconomic status (SES) was not linked with hidradenitis suppurativa (HS) in minors, but was associated with obesity and tobacco use in this age group.
European Commission Approves Secukinumab for Hidradenitis Suppurativa
June 1st 2023

European Commission Approves Secukinumab for Hidradenitis Suppurativa

Emma Andrus
The approval makes the drug Europe’s first and only interleukin (IL)-17A inhibitor approved for the condition.
Little children making circle with hands around each other indoors, top view. Unity concept: © New Africa - stock.adobe.com
May 27th 2023

Eczema Prevalence Findings Indicate Potential Diagnosis Disparities by Race

Maggie L. Shaw
With surveys demonstrating that care disparities in atopic dermatitis (AD) may exist among pediatric patients with the chronic skin condition, investigators set out to determine AD’s prevalence by sociodemographic subgroup.
Health insurance medicine safety finance treatment computer concept. Healthcare medical assurance help money premium healthy web technology: © wladimir1804 - stock.adobe.com
May 24th 2023

Wide Gaps Found in Insurance Coverage of Common Skin Conditions

Jared Kaltwasser
Although acne and rosacea treatment are widely covered, treatment for other types of skin conditions are not covered at all, a new report shows.
Melinda Gooderham, MD, MSc, FRCPC, Peterborough Regional Health Centre
May 18th 2023

Dr Melinda Gooderham Discusses Studies on Emerging Therapies for Atopic Dermatitis

Pearl Steinzor
Melinda Gooderham, MD, MSc, FRCPC, Peterborough Regional Health Centre in Ontario, Canada, discusses recent trials and studies that have been conducted on emerging therapies for patients with atopic dermatitis.
woman checking her skin for an abnormal mole for signs of melanoma skin cancer: © MW Photography - stock.adobe.com
May 16th 2023

Improvement Needed in Study Interventions to Better Skin Self-examination Adherence

Jaime Rosenberg
The study, using an adaption of the World Health Organization framework for adherence, characterized strategies built into the design, conduct, and reporting of melanoma trials, offering insights into potential improvements for skin self-examination in research.
Pimples on the belly of a pregnant woman,, home living room: © Андрей Журавлев - stock.adobe.com
May 7th 2023

Research Points to Inconsistencies in Acne Treatment for Pregnant Women

Gianna Melillo
Common treatments for acne are known to be unsafe for pregnant women, but alternative treatments exist that are safe for use; however, actual treatment patterns within this patient population are unclear.
Hands with different skin tones raised
May 2nd 2023

Disparities in AD Treatment: What Can Be Done?

Julia Bonavitacola
Reducing disparities in the treatment of atopic dermatitis (AD) was the focus of a session of the final day of the Revolutionizing Atopic Dermatitis 2023 conference.
Andy Blauvelt, MD, MBA, president, Oregon Medical Research Center
May 2nd 2023

Dr Andy Blauvelt on Selecting the Right Patient for Systemic Therapy or Biologics to Treat AD

Pearl Steinzor
Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses the use of systemic therapies vs biologics and why adherence is so important when treating patients with atopic dermatitis (AD).
Larry Eichenfield, MD, professor of dermatology and pediatrics, vice chair, Department of Dermatology at the University of California San Diego (UCSD) School of Medicine, and chief of pediatric and adolescent dermatology, Rady Children's Hospital San Diego
May 2nd 2023

Dr Larry Eichenfield: A Changing Therapy Landscape Provides More Options for Infants With AD

Pearl Steinzor
Larry Eichenfield, MD, professor of dermatology and pediatrics and vice chair of the Department of Dermatology at the University of California San Diego School of Medicine and chief of pediatric and adolescent dermatology at Rady Children's Hospital San Diego, discusses the use of different treatments and biologics for atopic dermatitis (AD) in infants, which he presented at the Revolutionizing Atopic Dermatitis conference.
Man scratching rash
May 1st 2023

Panel Focuses on Burgeoning Therapies in Atopic Dermatitis

Julia Bonavitacola
A panel held at Revolutionizing Atopic Dermatitis 2023 reviewed therapies to expect within the next year for the treatment of atopic dermatitis (AD) as well as investigational therapies currently undergoing trials.
<1234567891011>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo